JOHANNESBURG (Reuters) – African drugmaker Aspen Pharmacare is in advanced talks with partners to manufacture mpox vaccines at its facilities, Chief Executive Officer Stephen Saad told Reuters on Tuesday.
“We are speaking to people, we have the capabilities, we can do it,” he said in an interview.
(Reporting by Nqobile Dludla, Editing by Bhargav Acharya)
Comments